Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Emily Bodnar upgraded the rating for AnaptysBio, Inc. (NASDAQ:ANAB) from Neutral to Buy and raised the price target from $22 to $38. AnaptysBio shares closed at $23.52 on Tuesday. See how other analysts view this stock.
- Barclays analyst David Anderson upgraded Cactus, Inc. (NYSE:WHD) from Equal-Weight to Overweight …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Emily Bodnar upgraded the rating for AnaptysBio, Inc. (NASDAQ:ANAB) from Neutral to Buy and raised the price target from $22 to $38. AnaptysBio shares closed at $23.52 on Tuesday. See how other analysts view this stock.
- Barclays analyst David Anderson upgraded Cactus, Inc. (NYSE:WHD) from Equal-Weight to Overweight …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Emily Bodnar upgraded the rating for AnaptysBio, Inc. (NASDAQ:ANAB) from Neutral to Buy and raised the price target from $22 to $38. AnaptysBio shares closed at $23.52 on Tuesday. See how other analysts view this stock.
Barclays analyst David Anderson upgraded Cactus, Inc. (NYSE:WHD) from Equal-Weight to Overweight …Full story available on Benzinga.com Read MoreANAB, BPMC, ERJ, News, SNOW, top upgrades, WHD, Upgrades, Markets, Analyst Ratings, Trading Ideas, ERJ, US29082A1079, SNOW, BPMC, ANAB, WHD, News, Upgrades, Markets, Analyst Ratings, Trading Ideas, Benzinga News
